Target intelligence / Profile preview

Ribonuclease T1 (RNase T1)

Target
RNase T1
Molecular classification
Enzyme, Ribonuclease, Endonuclease, Phosphodiesterase
01

Overview

Ribonuclease T1 (RNase T1) is a small, 104-amino acid fungal endonuclease originally isolated from the mold Aspergillus oryzae [2, 20]. It is characterized by its high specificity for cleaving single-stranded RNA at the 3'-phosphodiester bond of guanine residues, a property that has made it an indispensable tool in molecular biology for RNA sequencing, fingerprinting, and structural studies [4, 11]. The enzyme's catalytic mechanism involves a two-step process: a transphosphorylation reaction forming a 2',3'-cyclic phosphate intermediate, followed by hydrolysis to a 3'-phosphate [1, 3, 20]. Due to its potent ribonucleolytic activity, RNase T1 and its derivatives have been explored as potential 'ribotoxins' for cancer therapy, where they can induce apoptosis by degrading cellular RNA and halting protein synthesis [3, 15, 18]. Despite this therapeutic potential, challenges such as immunogenicity and the requirement for targeted delivery to avoid non-specific toxicity remain significant hurdles [3, 15]. Additionally, RNase T1 serves as a prominent model system in biochemistry for studying protein folding, stability, and enzyme-substrate interactions [2, 20].

Other names
Guanyl-specific ribonuclease T1GuanyloribonucleaseAspergillus oryzae ribonucleaserntARNase T1
02

Mechanism of action

Cleavage of 3',5'-phosphodiester bonds of RNA specifically at guanine residues via a 2',3'-cyclic phosphate intermediate.

03

Biological functions

RNA degradationRNA processingGuanylic acid-specific cleavageEndonucleolytic cleavage
04

Disease associations

CancerInfection
05

Safety considerations

ImmunogenicityNon-specific cytotoxicityTherapeutic delivery challenges
06

Interacting drugs

Guanosine 3'-monophosphate

5 more in the full profile.

Beyond the preview

Go deeper on Ribonuclease T1 (RNase T1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonuclease T1 (RNase T1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call